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equivalence despite the simplicity of MPT versus CPET as 
a surrogate to detect DH in COPD patients, by measuring 
the decrease in inspiratory capacity to reflect the increase 
in end-expiratory lung volume  [3] . Lahaije et al.  [2] have 
investigated whether DH as measured in the laboratory 
settings (CPET and MPT) reflects DH that is associated 
with dyspnea-limiting ADL. The authors conclude that 
both CPET and MPT can serve as a screening tool to iden-
tify patients who are susceptible to develop DH during 
ADL. In practice, MPT is simpler to obtain and is an inex-
pensive surrogate. However, sensitivity of MPT may not be 
optimal. When DH does not occur during CPET, it is un-
likely to occur during ADL. The study also surprisingly 
demonstrated that one third of the study subjects with mild 
COPD experienced DH during ADL. However, the prog-
nostic value of this observation has yet to be established. 
Results in the present study extend previously published 
somewhat similar observations by the same authors  [4, 5] .
 Physicians should be aware that DH can occur in most 
symptomatic patients with COPD and may contribute to 
the problem of breathlessness during ADL. Revealing 
changes in the impact of COPD on a patient’s life can be 
more useful than demonstrating improvements in con-
ventional lung function. Therapeutic interventions to re-
 The international GOLD guidelines on the manage-
ment of chronic obstructive pulmonary diseases (COPD) 
recommend that both serial lung function studies includ-
ing spirometry and oxygen saturation at rest and during 
physical activity and overall health status should be regu-
larly assessed to properly manage the disease  [1] . The main 
subjective complaint of COPD patients with mild but es-
pecially moderate-to-severe expiratory airflow limitation 
is dyspnea associated with impaired exercise tolerance and 
progressive limitation of their activities of daily living 
(ADL)  [1] . It is now accepted that dyspnea is in part re-
lated to the perception of difficulty in breathing through 
narrowed or destroyed small airways <2 mm ID due to in-
creased peripheral intrinsic airway obstruction and vari-
able loss of lung elastic recoil due to superimposed emphy-
sema. Dyspnea is also related to resting and exercise-in-
duced dynamic hyperinflation (DH), which poses an 
elastic load on the respiratory system with resultant inspi-
ratory muscle weakness and eventually fatigue. In this set-
ting, the study by Lahaije et al.  [2] , published in this issue 
of  Respiration , highlights the importance of evaluating DH 
in a real-life setting during ADL, as well as during cardio-
pulmonary exercise testing (CPET) and metronome-paced 
tachypnea (MPT). We have previously demonstrated the 
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lieve dyspnea and reduce DH during ADL remain impor-
tant goals  [6, 7] . However, we recently demonstrated that 
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moderately severe COPD patients despite significant 
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compared to placebo and despite the varying extent of 
lung CT-scored emphysema  [8] . Unfortunately, this ther-
apeutic conundrum remains a challenge to physicians 
and a burden to COPD patients with DH during ADL.
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